PD-L1 is mainly involved in T cell activation, aggregation, and lymphocyte activation in tumor microenvironment, while CD86 is mainly involved in the positive regulation of cell adhesion and the proliferation of leukocytes and monocytes, and CD206 is mainly involved in type 2 immune response and protein complex involved in cell adhesion. The gene discussed is CD86; the disease is neoplasm.